Park Avenue Institutional Advisers’s Thermo Fisher Scientific TMO Stock Holding History

Park Avenue Institutional Advisers’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-2,503	Closed	-$370K	–	375
2016 Q2	$370K	Sell	2,503 -12	-0.5%	-$1.77K	0.32%	75
2016 Q1	$356K	Sell	2,515 -70	-3%	-$9.38K	0.31%	80
2015 Q4	$367K	Sell	2,585 -62	-2%	-$8.27K	0.32%	75
2015 Q3	$324K	Sell	2,647 -29	-1%	-$3.78K	0.29%	84
2015 Q2	$347K	Buy	+2,676	New	+$349K	0.28%	89

Other funds holding TMO

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Park Avenue Institutional Advisers's TMO Position: Q3 2016 in Review

Park Avenue Institutional Advisers sold out of Thermo Fisher Scientific (TMO) in Q3 2016, closing a stake of 2,503 shares — an estimated $370K sold.

Park Avenue Institutional Advisers first reported a position in TMO in Q2 2015 and held it in 5 quarters. The position peaked at $370K in Q2 2016. 1,044 funds tracked by Wall St. Rank hold TMO as of Q3 2016.

Park Avenue Institutional Advisers reported no remaining Thermo Fisher Scientific position as of Q3 2016 after selling out during the quarter.
Park Avenue Institutional Advisers sold 2,503 Thermo Fisher Scientific shares in Q3 2016, an estimated $370K.
Park Avenue Institutional Advisers first reported a position in Thermo Fisher Scientific in Q2 2015 and held it in 5 quarters.
Park Avenue Institutional Advisers's Thermo Fisher Scientific position peaked at $370K in Q2 2016.
1,044 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2016.

Based on Park Avenue Institutional Advisers's 13F filing for Q3 2016, filed 15 Feb 2017.